Choose your preferred way to stay informed of new case launches and settlement deadlines
The filed complaint alleges that STAAR Surgical Company made materially false and/or misleading statements and/or failed to disclose that: Staar reported disappointing earnings for Q4 2024, blaming the results on weak demand in China and a drop in refractive procedures. Following this news, shares of Staar fell over 24% on February 12, 2025. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
In order to be eligible to join the STAA class action lawsuit, you must have incurred a loss on shares of STAAR Surgical Company purchased during the class period listed above.
TOP
